Cargando…
Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
Advances in sequencing technology have enabled the genomic and transcriptomic characterization of human malignancies with unprecedented detail. However, this wealth of information has been slow to translate into clinically meaningful outcomes. Different models to study human cancers have been establ...
Autores principales: | Nguyen, Long V, Caldas, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422077/ https://www.ncbi.nlm.nih.gov/pubmed/34254730 http://dx.doi.org/10.15252/emmm.202013189 |
Ejemplares similares
-
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models
por: Geeleher, Paul, et al.
Publicado: (2016) -
A genomic approach to biomarker discovery in human autoimmune diseases
por: Pascual, V
Publicado: (2010) -
Aging Biomarkers for Clinical Trials and Drug Discovery
por: Meer, Margarita, et al.
Publicado: (2021) -
Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery Perspectives
por: Marugán, Carlos, et al.
Publicado: (2016) -
From Genome to Drugs: New Approaches in Antimicrobial Discovery
por: Serral, Federico, et al.
Publicado: (2021)